This manuscript reports the identification of hydrophobic interaction chromatography (HIC)-shifting, non-toxic linker-payload surrogates as tool molecules for the optimization of maleimide/cysteine conjugations relevant to antibody-drug conjugates (ADCs). These tool molecules are demonstrated to allow conjugation measurement via HIC with a mAb (mono-clonal antibody) bearing engineered cysteines, and for conjugation to mAb interchain cysteines. The linker/payload (LP) mimics were employed to optimize conjugations via high-throughput experimentation and employed to facilitate the development of continuous flow conjugations in a microfluidic reactor and on larger scale. Putative identification of the novel ADC mimics by HIC was confirmed by mass spectrometry. Overall, our studies provide confidence that commercially available, non-toxic LP mimics can be employed successfully to optimize ADC-type conjugations in batch and flow, while minimizing materials needs and experimental work in specialized facilities required for potent compound handling.
No takes yet. Share an insight, caveat, or question.
Bottecchia et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: